Literature DB >> 25569804

Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis.

Enkui Hao1,2, Partha Mukhopadhyay1, Zongxian Cao1, Katalin Erdélyi1, Eileen Holovac1, Lucas Liaudet3, Wen-Shin Lee1,4, György Haskó5, Raphael Mechoulam6, Pál Pacher1.   

Abstract

Doxorubicin (DOX) is a widely used, potent chemotherapeutic agent; however, its clinical application is limited because of its dose-dependent cardiotoxicity. DOX's cardiotoxicity involves increased oxidative/nitrative stress, impaired mitochondrial function in cardiomyocytes/endothelial cells and cell death. Cannabidiol (CBD) is a nonpsychotropic constituent of marijuana, which is well tolerated in humans, with antioxidant, antiinflammatory and recently discovered antitumor properties. We aimed to explore the effects of CBD in a well-established mouse model of DOX-induced cardiomyopathy. DOX-induced cardiomyopathy was characterized by increased myocardial injury (elevated serum creatine kinase and lactate dehydrogenase levels), myocardial oxidative and nitrative stress (decreased total glutathione content and glutathione peroxidase 1 activity, increased lipid peroxidation, 3-nitrotyrosine formation and expression of inducible nitric oxide synthase mRNA), myocardial cell death (apoptotic and poly[ADP]-ribose polymerase 1 [PARP]-dependent) and cardiac dysfunction (decline in ejection fraction and left ventricular fractional shortening). DOX also impaired myocardial mitochondrial biogenesis (decreased mitochondrial copy number, mRNA expression of peroxisome proliferator-activated receptor γ coactivator 1-alpha, peroxisome proliferator-activated receptor alpha, estrogen-related receptor alpha), reduced mitochondrial function (attenuated complex I and II activities) and decreased myocardial expression of uncoupling protein 2 and 3 and medium-chain acyl-CoA dehydrogenase mRNA. Treatment with CBD markedly improved DOX-induced cardiac dysfunction, oxidative/nitrative stress and cell death. CBD also enhanced the DOX-induced impaired cardiac mitochondrial function and biogenesis. These data suggest that CBD may represent a novel cardioprotective strategy against DOX-induced cardiotoxicity, and the above-described effects on mitochondrial function and biogenesis may contribute to its beneficial properties described in numerous other models of tissue injury.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25569804      PMCID: PMC4461586          DOI: 10.2119/molmed.2014.00261

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  44 in total

1.  Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity.

Authors:  Partha Mukhopadhyay; Sándor Bátkai; Mohanraj Rajesh; Nora Czifra; Judith Harvey-White; György Haskó; Zsuzsanna Zsengeller; Norma P Gerard; Lucas Liaudet; George Kunos; Pál Pacher
Journal:  J Am Coll Cardiol       Date:  2007-07-23       Impact factor: 24.094

Review 2.  New insights into doxorubicin-induced cardiotoxicity: the critical role of cellular energetics.

Authors:  Malgorzata Tokarska-Schlattner; Michael Zaugg; Christian Zuppinger; Theo Wallimann; Uwe Schlattner
Journal:  J Mol Cell Cardiol       Date:  2006-08-01       Impact factor: 5.000

3.  Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation.

Authors:  Yoshihiko Ichikawa; Mohsen Ghanefar; Marina Bayeva; Rongxue Wu; Arineh Khechaduri; Sathyamangla V Naga Prasad; R Kannan Mutharasan; Tejaswitha Jairaj Naik; Hossein Ardehali
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

4.  Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption.

Authors:  Mohanraj Rajesh; Partha Mukhopadhyay; Sándor Bátkai; György Haskó; Lucas Liaudet; Viktor R Drel; Irina G Obrosova; Pál Pacher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-03-23       Impact factor: 4.733

5.  Activation of poly(ADP-ribose) polymerase contributes to development of doxorubicin-induced heart failure.

Authors:  P Pacher; L Liaudet; P Bai; L Virag; J G Mabley; G Haskó; C Szabó
Journal:  J Pharmacol Exp Ther       Date:  2002-03       Impact factor: 4.030

Review 6.  Adriamycin-induced oxidative mitochondrial cardiotoxicity.

Authors:  J M Berthiaume; K B Wallace
Journal:  Cell Biol Toxicol       Date:  2006-09-28       Impact factor: 6.691

Review 7.  Nitric oxide and peroxynitrite in health and disease.

Authors:  Pál Pacher; Joseph S Beckman; Lucas Liaudet
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

8.  Cannabidiol arrests onset of autoimmune diabetes in NOD mice.

Authors:  Lola Weiss; Michael Zeira; Shoshana Reich; Shimon Slavin; Itamar Raz; Raphael Mechoulam; Ruth Gallily
Journal:  Neuropharmacology       Date:  2007-07-17       Impact factor: 5.250

Review 9.  Doxorubicin-induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy.

Authors:  Filipa S Carvalho; Ana Burgeiro; Rita Garcia; António J Moreno; Rui A Carvalho; Paulo J Oliveira
Journal:  Med Res Rev       Date:  2013-03-11       Impact factor: 12.944

10.  Doxorubicin inactivates myocardial cytochrome c oxidase in rats: cardioprotection by Mito-Q.

Authors:  Karunakaran Chandran; Deepika Aggarwal; Raymond Q Migrino; Joy Joseph; Donna McAllister; Eugene A Konorev; William E Antholine; Jacek Zielonka; Satish Srinivasan; Narayan G Avadhani; B Kalyanaraman
Journal:  Biophys J       Date:  2009-02-18       Impact factor: 4.033

View more
  38 in total

1.  Chronic plus binge ethanol feeding induces myocardial oxidative stress, mitochondrial and cardiovascular dysfunction, and steatosis.

Authors:  Csaba Matyas; Zoltan V Varga; Partha Mukhopadhyay; Janos Paloczi; Tamas Lajtos; Katalin Erdelyi; Balazs T Nemeth; Mintong Nan; Gyorgy Hasko; Bin Gao; Pal Pacher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-04-22       Impact factor: 4.733

Review 2.  Role of the endocannabinoid system in diabetes and diabetic complications.

Authors:  G Gruden; F Barutta; G Kunos; P Pacher
Journal:  Br J Pharmacol       Date:  2015-08-20       Impact factor: 8.739

3.  Emerging Roles of Cannabinoids and Synthetic Cannabinoids in Clinical Experimental Models.

Authors:  Paula Morales; Patricia H Reggio
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Pharmacological Properties of the Plant-Derived Natural products Cannabinoids and Implications for Cardiovascular Health.

Authors:  Luca Liberale; Fabrizio Montecucco; Federico Carbone
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Drug-induced mitochondrial dysfunction and cardiotoxicity.

Authors:  Zoltán V Varga; Peter Ferdinandy; Lucas Liaudet; Pál Pacher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-18       Impact factor: 4.733

Review 6.  Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly.

Authors:  Pal Pacher; Sabine Steffens; György Haskó; Thomas H Schindler; George Kunos
Journal:  Nat Rev Cardiol       Date:  2017-09-14       Impact factor: 32.419

Review 7.  Melatonin and cannabinoids: mitochondrial-targeted molecules that may reduce inflammaging in neurodegenerative diseases.

Authors:  Sebastián García; Virna Margarita Martín Giménez; Feres José Mocayar Marón; Russel J Reiter; Walter Manucha
Journal:  Histol Histopathol       Date:  2020-03-10       Impact factor: 2.303

8.  Cannabidiol Limits T Cell-Mediated Chronic Autoimmune Myocarditis: Implications to Autoimmune Disorders and Organ Transplantation.

Authors:  Wen-Shin Lee; Katalin Erdelyi; Csaba Matyas; Partha Mukhopadhyay; Zoltan V Varga; Lucas Liaudet; György Haskú; Daniela Čiháková; Raphael Mechoulam; Pal Pacher
Journal:  Mol Med       Date:  2016-01-08       Impact factor: 6.354

Review 9.  [Cannabidiol in cancer treatment].

Authors:  Rudolf Likar; Markus Köstenberger; Gerhard Nahler
Journal:  Schmerz       Date:  2020-04       Impact factor: 1.107

Review 10.  Regulatory Effects of Cannabidiol on Mitochondrial Functions: A Review.

Authors:  John Zewen Chan; Robin Elaine Duncan
Journal:  Cells       Date:  2021-05-19       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.